# Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics

> **NCT00486291** · PHASE2 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 210 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** VI-0521
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00486291
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2012-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486291, "Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00486291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*